Your browser doesn't support javascript.
loading
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh, Donald C; Gouin, Jean-Philippe; Cruz-Santiago, Diana; Canac-Marquis, Michelle; Bernier, Stéphane; Bobeuf, Florian; Sengupta, Avik; Brassard, Jean-Philippe; Guerra, Alyssa; Dziarmaga, Robert; Perez, Anna; Sun, Yichun; Li, Yongbiao; Roussel, Lucie; Langelier, Mélanie J; Ke, Danbing; Arnold, Corey; Whelan, Marilyn; Pelchat, Martin; Langlois, Marc-André; Zhang, Xun; Mazer, Bruce D.
Afiliación
  • Vinh DC; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Gouin JP; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada.
  • Cruz-Santiago D; Centre de recherche de l'Institut de gériatrie de Montréal, Montréal, QC, Canada.
  • Canac-Marquis M; Department of Psychology, Faculty of Arts and Sciences, Concordia University, Montréal, QC, Canada.
  • Bernier S; Centre de recherche de l'Institut de gériatrie de Montréal, Montréal, QC, Canada.
  • Bobeuf F; Département de médecine de famille et médecine urgence, Université de Montréal, Montréal, QC, Canada.
  • Sengupta A; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Brassard JP; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Guerra A; Centre de recherche de l'Institut de gériatrie de Montréal, Montréal, QC, Canada.
  • Dziarmaga R; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Perez A; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Sun Y; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Li Y; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Roussel L; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Langelier MJ; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Ke D; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Arnold C; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Whelan M; Infectious Diseases and Immunity in Global Health program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Pelchat M; Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Langlois MA; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Zhang X; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Mazer BD; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Lancet Healthy Longev ; 3(3): e166-e175, 2022 03.
Article en En | MEDLINE | ID: mdl-35224524
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Lancet Healthy Longev Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Lancet Healthy Longev Año: 2022 Tipo del documento: Article País de afiliación: Canadá